Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients (Q34015375)

30 July 2017

1 reference

title

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients (English)

1 reference

30 July 2017

0 references

1 reference

2

Matthew E Falagas

1 reference

30 July 2017

author name string

Argyris S Michalopoulos

series ordinal

1

1 reference

30 July 2017

publication date

2 August 2011

1 reference

30 July 2017

published in

Annals of Intensive Care

1 reference

30 July 2017

volume

1

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

30

1 reference

Creative Commons Attribution 2.0 Generic

30 July 2017

copyright license

start time

2 August 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Penetration of colistin into cerebrospinal fluid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Nephrotoxicity of intravenous colistin: a prospective evaluation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis. Case report and review of the literature

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Colistin and polymyxin B: a re-emergence

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Pharmacokinetics of inhaled colistin in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Intrathecal colistin and sterilization of resistant Pseudomonas aeruginosa shunt infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Nephrotoxicity associated with the use of intravenous colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Clinical characteristics and risk factors of colistin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Colistin administration to pediatric and neonatal patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-1-30

Serum bactericidal activity of three different dosing regimens of colistin with implications for optimum clinical use.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Nebulized and intravenous colistin in experimental pneumonia caused by Pseudomonas aeruginosa

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Serum and Urine Levels Following Parenteral Administration of Sodium Colistimethate to Normal Individuals

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3224467

Intravenous colistin administration in neonates

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21906382

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21906382

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2110-5820-1-30

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference